All In Biotech

Free tool

FAERS Monitor: Barhemsys

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209510 or its brand name (Barhemsys, Amisulpride). Reports on generic versions are filed under their own applications.

Reports

6,123

Serious

6,004

98% of reports

Hospitalization

3,019

Death reported

796

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective872
  • drug interaction483
  • weight increased446
  • toxicity to various agents416
  • neutropenia408
  • schizophrenia339
  • off label use333
  • leukopenia316
  • akathisia307
  • extrapyramidal disorder302
  • electrocardiogram qt prolonged283
  • suicide attempt282
  • somnolence280
  • drug abuse261
  • confusional state247

Reports by year received

View as table
YearReports
200432
200549
200665
200779
200875
2009111
2010162
2011189
2012194
2013229
2014224
2015223
2016216
2017287
2018376
2019451
2020379
2021397
2022481
2023469
2024635
2025467
2026331

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,036 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
schizophreniaSignal33998.688.731,747
akathisiaSignal30779.070.823,062
extrapyramidal disorderSignal30242.337.811,996
electrocardiogram qt prolongedSignal28327.224.37,082
leukopeniaSignal31621.819.66,236
suicide attemptSignal28216.014.33,956
drug abuseSignal26110.89.62,313
drug interactionSignal48310.59.64,155
neutropeniaSignal40810.39.43,443
toxicity to various agentsSignal4168.57.72,758
weight increasedSignal4466.96.32,243
confusional stateSignal2475.34.7853
somnolenceSignal2804.84.3841
drug ineffectiveSignal8722.32.1662
off label use3331.31.225

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.